Management begins with confirming the infection through suitable diagnostic testing. HIV-2 diagnosis may require specialized testing because some routine HIV tests cannot distinguish between HIV-1 and HIV-2. Accurate identification helps healthcare professionals choose appropriate treatments.
Diagnostic confirmation: Specialized tests help distinguish HIV-2 from HIV-1 and confirm the infection.
Immune assessment: CD4 cell counts help evaluate immune system function and disease progression.
Treatment planning: Healthcare professionals consider the infection type, medical history, laboratory findings, and medication suitability.
Regular monitoring: Follow-up appointments help evaluate treatment response, immune health, and possible complications.
Antiviral activity research focuses on understanding how medicines interfere with viral replication and limit the ability of HIV-2 to infect additional cells. HIV-2 has different susceptibility patterns from HIV-1, making the selection of suitable antiretroviral medicines particularly important.
Certain medication classes demonstrate activity against HIV-2, while others that are commonly used for HIV-1 may have limited effectiveness against HIV-2. Treatment approaches generally rely on combination antiretroviral therapy, with medication selection guided by established clinical recommendations and specialist assessment.
Drug effectiveness: Researchers study how different antiretroviral compounds suppress HIV-2 replication.
Resistance monitoring: Testing and clinical evaluation help identify potential resistance that may affect treatment response.
Combination therapies: Using multiple active medicines helps suppress viral replication and reduce the risk of resistance.
Ongoing research: Investigations explore viral characteristics, drug targets, treatment outcomes, and improved therapeutic approaches.
Advances in antiviral research and accurate diagnosis continue to strengthen HIV-2 management, helping healthcare professionals make informed treatment decisions and support long-term patient health.